| Symbol |
Name |
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ATF1
|
activating transcription factor 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CALD1
|
caldesmon 1
|
|
CANX
|
calnexin
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CTTN
|
cortactin
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ESR1
|
estrogen receptor 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FPR1
|
formyl peptide receptor 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
H2AFX
|
H2A histone family, member X
|
|
H3F3B
|
H3 histone, family 3B (H3.3B)
|
|
HDAC2
|
histone deacetylase 2
|
|
HIST1H1A
|
histone cluster 1, H1a
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IRS1
|
insulin receptor substrate 1
|
|
JUN
|
jun proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRT8
|
keratin 8, type II
|
|
LIPE
|
lipase, hormone-sensitive
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MKNK2
|
MAP kinase interacting serine/threonine kinase 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NOXA1
|
NADPH oxidase activator 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
PCYT1A
|
phosphate cytidylyltransferase 1, choline, alpha
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2
|
|
PGR
|
progesterone receptor
|
|
PKN1
|
protein kinase N1
|
|
PKN2
|
protein kinase N2
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PXN
|
paxillin
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RB1
|
retinoblastoma 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RGS19
|
regulator of G-protein signaling 19
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SORBS3
|
sorbin and SH3 domain containing 3
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TH
|
tyrosine hydroxylase
|
|
TOB1
|
transducer of ERBB2, 1
|
|
TP53
|
tumor protein p53
|
|
VIM
|
vimentin
|
|
ZC3HC1
|
zinc finger, C3HC-type containing 1
|